Robert Shen is an accomplished inventor based in North Wales, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on improving drug formulations to enhance therapeutic effects.

Latest Patents

One of Robert Shen's latest patents is for a modified release solid or semi-solid dosage form. This invention comprises non-steroidal anti-inflammatory drugs, particularly propionic acid derivatives like ibuprofen, combined with a second active ingredient that has a shorter therapeutically effective plasma concentration duration, such as phenylephrine. This method provides improved therapeutic effects, particularly pain relief along with decongestant relief, over extended time periods. Another notable patent is for chewable enteric coated aspirin tablets. This invention relates to a tablet that can be chewed or disintegrated in the oral cavity, which includes an enteric coated aspirin active ingredient and a lightly compressed matrix comprising directly compressible carbohydrates and at least one sweetener.

Career Highlights

Throughout his career, Robert Shen has worked with prominent companies such as McNeil-PPC, Inc. and Johnson & Johnson Consumer Inc. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical industry.

Collaborations

Robert has collaborated with notable professionals in his field, including Der-Yang Lee and Vincent Chen. Their combined expertise has contributed to the success of his inventions.

Conclusion

Robert Shen's innovative work in pharmaceutical formulations demonstrates his commitment to enhancing therapeutic outcomes. His patents reflect a deep understanding of drug delivery systems and their impact on patient care.

This text is generated by artificial intelligence and may not be accurate.